Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
Circulation
    April 2018
  1. DE LA SIERRA A, Banegas JR, Vinyoles E, Segura J, et al
    Prevalence of Masked Hypertension in Untreated and Treated Patients With Office Blood Pressure Below 130/80 mm Hg.
    Circulation. 2018 Apr 30. pii: CIRCULATIONAHA.118.034619.
    >> Share

  2. LEOPOLD JA
    Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.
    Circulation. 2018;137:1811-1813.
    >> Share

  3. KIKUCHI N, Satoh K, Kurosawa R, Yaoita N, et al
    Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target.
    Circulation. 2018 Apr 10. pii: CIRCULATIONAHA.117.033113.
    >> Share

    March 2018
  4. SOLIMAN EZ, Ambrosius WT, Lewis CE
    Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1300-1301.
    >> Share

  5. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1299.
    >> Share

  6. LEWIS GA, Schelbert EB, Miller CA
    Letter by Lewis et al Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".
    Circulation. 2018;137:1297-1298.
    >> Share

  7. TURER CB, Brady TM, de Ferranti SD
    Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.
    Circulation. 2018;137:1256-1259.
    >> Share

  8. AUBDOOL AA, Argunhan F, Thakore P, Brain SD, et al
    Response by Aubdool et al to Letters Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1201-1202.
    >> Share

  9. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1200.
    >> Share

  10. TSUDA K
    Letter by Tsuda Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1198-1199.
    >> Share

    February 2018
  11. HEMNES AR, Brittain EL
    Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest.
    Circulation. 2018;137:925-927.
    >> Share

  12. MANCIA G, Corrao G
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Italy.
    Circulation. 2018;137:889-890.
    >> Share

  13. BRUNSTROM M, Carlberg B, Lindholm LH
    Perspective From Sweden on the Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A "Sprint" Beyond Evidence in the United States.
    Circulation. 2018;137:886-888.
    >> Share

  14. SCHIFFRIN EL
    Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Canada.
    Circulation. 2018;137:883-885.
    >> Share

  15. WANG Z, Chen Z, Zhang L, Wang X, et al
    Status of Hypertension in China: Results from the China Hypertension Survey, 2012-2015.
    Circulation. 2018 Feb 15. pii: CIRCULATIONAHA.117.032380.
    >> Share

  16. DUMAS SJ, Bru-Mercier G, Courboulin A, Quatredeniers M, et al
    NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Circulation. 2018 Feb 14. pii: CIRCULATIONAHA.117.029930.
    >> Share

  17. RUBIN LJ
    Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic Measurements.
    Circulation. 2018;137:705-706.
    >> Share

  18. COOPER R
    Hypertension, Genes, and Environment: Challenges for Prevention and Risk Prediction.
    Circulation. 2018;137:662-664.
    >> Share

  19. WANDER GS, Ram CVS
    Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From India.
    Circulation. 2018;137:549-550.
    >> Share

  20. WANG JG, Liu L
    Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From China.
    Circulation. 2018;137:546-548.
    >> Share

  21. KARIO K
    Global Impact of 2017 American Heart Association/American College of Cardiology Hypertension Guidelines: A Perspective From Japan.
    Circulation. 2018;137:543-545.
    >> Share

  22. CHEN KH, Dasgupta A, Lin J, Potus F, et al
    Epigenetic Dysregulation of the Drp1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
    Circulation. 2018 Feb 5. pii: CIRCULATIONAHA.117.031258.
    >> Share

    January 2018
  23. HSU S, Kokkonen-Simon KM, Kirk JA, Kolb TM, et al
    Right Ventricular Myofilament Functional Differences in Humans with Systemic Sclerosis-associated versus Idiopathic Pulmonary Arterial Hypertension.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.033147.
    >> Share

  24. ZANCHETTI A, Thomopoulos C
    Benefits and Risks of Antihypertensive Treatment: How Far Can Diastolic Blood Pressure Be Lowered?
    Circulation. 2018;137:144-147.
    >> Share

  25. BOYD HA, Basit S, Wohlfahrt J, Oyen N, et al
    Response by Boyd et al to Letter Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".
    Circulation. 2018;137:97-98.
    >> Share

  26. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies".
    Circulation. 2018;137:95-96.
    >> Share

    December 2017
  27. ARCHER SL
    Pyruvate Kinase and Warburg Metabolism in Pulmonary Arterial Hypertension: Uncoupled Glycolysis and the Cancer-Like Phenotype of Pulmonary Arterial Hypertension.
    Circulation. 2017;136:2486-2490.
    >> Share

  28. FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
    Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
    >> Share

  29. KALKMAN DN, Brouwer TF, Vehmeijer JT, Berger WR, et al
    J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm.
    Circulation. 2017;136:2220-2229.
    >> Share

    November 2017
  30. CAILLON A, Huo KG, Paradis P, Schiffrin EL, et al
    Response by Caillon et al to Letter Regarding Article, "gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury".
    Circulation. 2017;136:2200-2201.
    >> Share

  31. CAMPBELL DJ
    Letter by Campbell Regarding Article, "gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury".
    Circulation. 2017;136:2198-2199.
    >> Share

  32. DA SILVA GONCALVES BOS D, Van Der Bruggen CE, Kurakula K, Sun XQ, et al
    Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.027451.
    >> Share

  33. CULLEY MK, Chan SY
    Human Endogenous Retrovirus K and Pulmonary Arterial Hypertension: A New Take on a Retro Idea.
    Circulation. 2017;136:1936-1938.
    >> Share

  34. SCHIAVON CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, et al
    Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
    Circulation. 2017 Nov 13. pii: CIRCULATIONAHA.117.032130.
    >> Share

    October 2017
  35. WEATHERALD J, Boucly A, Chemla D, Savale L, et al
    The Prognostic Value of Follow-up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Circulation. 2017 Oct 25. pii: CIRCULATIONAHA.117.029254.
    >> Share

  36. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    >> Share

  37. CARNETHON MR, Pu J, Howard G, Albert MA, et al
    Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Oct 23. pii: CIR.0000000000000534.
    >> Share

    September 2017
  38. HADINNAPOLA C, Bleda M, Haimel M, Screaton N, et al
    Phenotypic Characterisation of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically with Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 28. pii: CIRCULATIONAHA.117.028351.
    >> Share

  39. NIIRANEN TJ, Larson MG, McCabe EL, Xanthakis V, et al
    Prognosis of Prehypertension Without Progression to Hypertension.
    Circulation. 2017;136:1262-1264.
    >> Share

  40. ZHANG H, Wang D, Li M, Plecita-Hlavata L, et al
    The Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension is Regulated through a MiR-124/PTBP1/PKM Axis.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028069.
    >> Share

  41. CARUSO P, Dunmore BJ, Schlosser K, Schoors S, et al
    Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028034.
    >> Share

  42. SAITO T, Miyagawa K, Chen SY, Tamosiuniene R, et al
    Upregulation of HERV-K is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Circulation. 2017 Sep 21. pii: CIRCULATIONAHA.117.027589.
    >> Share

  43. HUANG C, Moran AE, Coxson PG, Yang X, et al
    Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China.
    Circulation. 2017 Sep 7. pii: CIRCULATIONAHA.116.026487.
    >> Share

    August 2017
  44. LI H, Cai J, Chen R, Zhao Z, et al
    Particulate Matter Exposure and Stress Hormone Levels: A Randomized, Double-Blind, Crossover Trial of Air Purification.
    Circulation. 2017;136:618-627.
    >> Share

  45. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation. 2017;136:583-596.
    >> Share


  46. Correction to: Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Circulation. 2017;136:e136.
    >> Share

    July 2017
  47. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    >> Share

    June 2017
  48. STERGIOU GS, Ntineri A, Kollias A
    Defining Ambulatory Blood Pressure Thresholds for Decision Making in Hypertension: The Effect of Race and Methodology.
    Circulation. 2017;135:2481-2484.
    >> Share

  49. RAVENELL J, Shimbo D, Booth JN 3rd, Sarpong DF, et al
    Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Circulation. 2017;135:2470-2480.
    >> Share

  50. TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
    Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
    >> Share

  51. MCEVOY JW, Blaha MJ
    Response by McEvoy and Blaha to Letter Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1113-e1114.
    >> Share

  52. HARBAOUI B, Courand PY, Lantelme P
    Letter by Harbaoui et al Regarding Article, "Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy".
    Circulation. 2017;135:e1111-e1112.
    >> Share

    May 2017
  53. SAG CM, Schnelle M, Zhang J, Murdoch CE, et al
    Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.
    Circulation. 2017;135:2163-2177.
    >> Share

  54. DAVIS J
    Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
    Circulation. 2017;135:2058-2061.
    >> Share

  55. SOLIMAN EZ, Ambrosius WT, Cushman WC, Zhang ZM, et al
    Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients with Hypertension: The Systolic Blood Pressure Intervention (SPRINT) Trial.
    Circulation. 2017 May 16. pii: CIRCULATIONAHA.117.028441.
    >> Share

    April 2017
  56. AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
    A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
    >> Share

  57. PHILLIPS RA
    Hypertension Treatment and Outcomes in the Era of Population Health, Coordinated Care, and Medicare Access and CHIP Reauthorization Act (MACRA).
    Circulation. 2017;135:1629-1631.
    >> Share

  58. BRESS AP, Kramer H, Khatib R, Beddhu S, et al
    Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examina
    Circulation. 2017;135:1617-1628.
    >> Share

  59. BOYD HA, Basit S, Behrens I, Leirgul E, et al
    Association Between Fetal Congenital Heart Defects and Maternal Risk of Hypertensive Disorders of Pregnancy in the Same Pregnancy and Across Pregnancies.
    Circulation. 2017 Apr 19. pii: CIRCULATIONAHA.116.024600.
    >> Share

    March 2017
  60. HWANGBO C, Lee HW, Kang H, Ju H, et al
    Modulation of Endothelial BMPR2 Activity by VEGFR3 in Pulmonary Arterial Hypertension.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.025390.
    >> Share

  61. CAILLON A, Mian MO, Fraulob-Aquino JC, Huo KG, et al
    Gamma Delta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Circulation. 2017 Mar 22. pii: CIRCULATIONAHA.116.027058.
    >> Share

  62. LI Y, Li Z, Zhang C, Li P, et al
    Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
    >> Share

    February 2017
  63. CHEN J, Sysol JR, Singla S, Zhao S, et al
    Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and is a Therapeutic Target in Pulmonary Arterial Hypertension.
    Circulation. 2017 Feb 15. pii: CIRCULATIONAHA.116.024557.
    >> Share

    January 2017
  64. YANG P, Read C, Kuc RE, Buonincontri G, et al
    Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension.
    Circulation. 2017 Jan 30. pii: CIRCULATIONAHA.116.023218.
    >> Share

  65. WHELTON SP, Blumenthal RS
    Beyond the Headlines: Insights on Potassium Supplementation for the Treatment of Hypertension From the Canadian Hypertension Education Program Guidelines (CHEP).
    Circulation. 2017;135:3-4.
    >> Share

  66. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    >> Share

    December 2016
  67. INAMI T, Kataoka M, Yanagisawa R, Ishiguro H, et al
    Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2016;134:2030-2032.
    >> Share

  68. MARQUES FZ, Nelson EM, Chu PY, Horlock D, et al
    High Fibre Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in DOCA-Salt Hypertensive Mice.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.024545.
    >> Share

  69. WILLIAMS B
    Time to Abandon Clinic Blood Pressure for the Diagnosis of Hypertension?
    Circulation. 2016;134:1808-1811.
    >> Share

  70. SCHWARTZ JE, Burg MM, Shimbo D, Broderick JE, et al
    Clinic Blood Pressure Underestimates Ambulatory Blood Pressure in an Untreated Employer-Based US Population: Results From the Masked Hypertension Study.
    Circulation. 2016;134:1794-1807.
    >> Share

    November 2016
  71. MCEVOY JW, Martin SS, Dardari ZA, Miedema MD, et al
    Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.025471.
    >> Share

  72. RHODES CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, et al
    Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.024602.
    >> Share

  73. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    >> Share

  74. WALSH KB, Woo D, Sekar P, Osborne J, et al
    Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics.
    Circulation. 2016;134:1444-1452.
    >> Share

  75. ST-ONGE MP, Grandner MA, Brown D, Conroy MB, et al
    Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e367-e386.
    >> Share

    October 2016
  76. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    >> Share

    September 2016
  77. MONTANIEL KR, Harrison DG
    Is Hypertension a Bone Marrow Disease?
    Circulation. 2016 Sep 27. pii: CIRCULATIONAHA.116.024520.
    >> Share

  78. WANG L, Zhao XC, Cui W, Ma YQ, et al
    Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction.
    Circulation. 2016 Sep 27. pii: CIRCULATIONAHA.115.020754.
    >> Share


  79. Correction to: Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension.
    Circulation. 2016;134:e260.
    >> Share

  80. LONN EM, Yusuf S
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mmHg Target?: An Antagonist View from HOPE-3.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023264.
    >> Share

  81. OPARIL S, Lewis CE
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to < 120/80 mmHg Target?: A Protagonist View from SPRINT.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023263.
    >> Share

    August 2016
  82. AZIZI M, Pereira H, Hamdidouche I, Gosse P, et al
    Adherence to Antihypertensive Treatment and the Blood Pressure Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.022922.
    >> Share

  83. CALHOUN DA
    Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension.
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024385.
    >> Share

  84. VAN DER BRUGGEN CE, Happe CM, Goumans MJ, Bogaard HJ, et al
    Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e117-8.
    >> Share

  85. KATAOKA M, Satoh T, Fukuda K
    Letter by Kataoka et al Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".
    Circulation. 2016;134:e115-6.
    >> Share

  86. LI M, Riddle S, Zhang H, D'Alessandro A, et al
    Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Co-Repressor C-terminal Binding Protein-1.
    Circulation. 2016 Aug 25. pii: CIRCULATIONAHA.116.023171.
    >> Share

  87. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    >> Share

  88. LI H, Zhang X, Wang F, Zhou L, et al
    MiR-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats By Up-Regulating Mitochondrial Translation.
    Circulation. 2016 Aug 19. pii: CIRCULATIONAHA.116.023926.
    >> Share

  89. LAI YC, Gladwin MT
    Response by Lai and Gladwin to Letter Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fractio
    Circulation. 2016;134:e79-80.
    >> Share

  90. CARLSTROM M, Lundberg JO
    Letter by Carlstrom and Lundberg Regarding Article, "SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction".
    Circulation. 2016;134:e77-8.
    >> Share

  91. MORAN AE
    Still on the Road to Worldwide Hypertension Control.
    Circulation. 2016;134:451-4.
    >> Share

  92. MILLS KT, Bundy JD, Kelly TN, Reed JE, et al
    Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.
    Circulation. 2016;134:441-50.
    >> Share

  93. O'GARA PT
    Management of Hypertension in Patients with Mild-to-Moderate Aortic Stenosis: Navigating the SEAS.
    Circulation. 2016 Aug 2. pii: CIRCULATIONAHA.116.023688.
    >> Share

  94. NIELSEN OW, Sajadieh A, Sabbah M, Greve AM, et al
    Assessing Optimal Blood Pressure in Patients with Asymptomatic Aortic Valve Stenosis: The SEAS Study.
    Circulation. 2016 Aug 2. pii: CIRCULATIONAHA.115.021213.
    >> Share

    July 2016
  95. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    >> Share

  96. BHATT DL, Gersh BJ
    Ruminations About Renal Denervation.
    Circulation. 2016;134:267-9.
    >> Share

    May 2016
  97. PRESTON IR, Roberts KE, Miller DP, Sen GP, et al
    Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e662.
    >> Share

  98. NIKPOUR M, Prior D, Celermajer D
    Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
    Circulation. 2016;133:e661.
    >> Share

  99. FUJIMOTO T, Morofuji Y, Horie N, Izumo T, et al
    One Cause of Secondary Hypertension: Neurogenic Etiology.
    Circulation. 2016;133:1985-6.
    >> Share

  100. HSU S, Houston BA, Tampakakis E, Bacher AC, et al
    Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.022082.
    >> Share

  101. MARON BA
    Independence Day: Separating Right Ventricular Function from Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Circulation. 2016 May 11. pii: CIRCULATIONAHA.116.023237.
    >> Share

    April 2016
  102. DAI Z, Li M, Wharton J, Zhu MM, et al
    PHD2 Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans through HIF-2alpha.
    Circulation. 2016 Apr 25. pii: CIRCULATIONAHA.116.021494.
    >> Share

  103. BAUDRAND R, Pojoga L, Vaidya A, Garza A, et al
    Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
    Circulation. 2016;133:e606.
    >> Share

  104. CAMPBELL DJ
    Letter by Campbell Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
    Circulation. 2016;133:e605.
    >> Share

  105. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    >> Share

  106. HOEPER MM
    Residual Pulmonary Hypertension After Pulmonary Endarterectomy: The Fog is Clearing.
    Circulation. 2016 Apr 6. pii: CIRCULATIONAHA.116.022595.
    >> Share


  107. ECG Response: April 5, 2016.
    Circulation. 2016;133:1419-20.
    >> Share

  108. ARANY Z, Elkayam U
    Peripartum Cardiomyopathy.
    Circulation. 2016;133:1397-409.
    >> Share

  109. HOPPER RK, Moonen JA, Diebold I, Cao A, et al
    In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and its Target Slug.
    Circulation. 2016 Apr 4. pii: CIRCULATIONAHA.115.020617.
    >> Share

    March 2016
  110. BRITTAIN EL, Talati M, Fessel JP, Zhu H, et al
    Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension.
    Circulation. 2016 Mar 22. pii: CIRCULATIONAHA.115.019351.
    >> Share

  111. CHIU P, Irons M, van de Rijn M, Liang DH, et al
    Giant Pulmonary Artery Aneurysm in a Patient With Marfan Syndrome and Pulmonary Hypertension.
    Circulation. 2016;133:1218-21.
    >> Share


  112. ECG Response: March 22, 2016.
    Circulation. 2016;133:1217.
    >> Share

  113. VAN DER BRUGGEN CE, Happe CM, Dorfmuller P, Trip P, et al
    Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    Circulation. 2016 Mar 16. pii: CIRCULATIONAHA.115.020696.
    >> Share

  114. HUBERS SA, Brown NJ
    Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Circulation. 2016;133:1115-24.
    >> Share

  115. KOENE RJ, Prizment AE, Blaes A, Konety SH, et al
    Shared Risk Factors in Cardiovascular Disease and Cancer.
    Circulation. 2016;133:1104-14.
    >> Share

  116. LUFT FC
    11-beta Hydroxysteroid Dehydrogenase-2 and Salt-Sensitive Hypertension.
    Circulation. 2016 Mar 7. pii: CIRCULATIONAHA.116.022038.
    >> Share

  117. EVANS LC, Ivy JR, Wyrwoll C, McNairn JA, et al
    Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension.
    Circulation. 2016 Mar 7. pii: CIRCULATIONAHA.115.019341.
    >> Share

  118. HALL JE
    Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension.
    Circulation. 2016;133:894-906.
    >> Share

  119. MORRIS RC JR, Schmidlin O, Sebastian A, Tanaka M, et al
    Vasodysfunction That Involves Renal Vasodysfunction, Not Abnormally Increased Renal Retention of Sodium, Accounts for the Initiation of Salt-Induced Hypertension.
    Circulation. 2016;133:881-93.
    >> Share

  120. MORRIS RC JR, Schmidlin O, Sebastian A, Tanaka M, et al
    Response to Hall.
    Circulation. 2016;133:907.
    >> Share

    February 2016
  121. ANTIGNY F, Hautefort A, Meloche J, Belacel-Ouari M, et al
    Potassium-Channel Subfamily K-Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Circulation. 2016 Feb 24. pii: CIRCULATIONAHA.115.020951.
    >> Share

  122. SCHWALM JD, McKee M, Huffman MD, Yusuf S, et al
    Resource Effective Strategies to Prevent and Treat Cardiovascular Disease.
    Circulation. 2016;133:742-55.
    >> Share

  123. MARON BA, Hess E, Maddox TM, Opotowsky AR, et al
    Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the VA-CART Program.
    Circulation. 2016 Feb 12. pii: CIRCULATIONAHA.115.020207.
    >> Share

  124. BOBROW K, Farmer AJ, Springer D, Shanyinde M, et al
    Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial.
    Circulation. 2016;133:592-600.
    >> Share

  125. LAUFFENBURGER JC, Choudhry NK
    Text Messaging and Patient Engagement in an Increasingly Mobile World.
    Circulation. 2016;133:555-6.
    >> Share

    January 2016
  126. DELCROIX M, Lang I, Pepke-Zaba J, Jansa P, et al
    Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry.
    Circulation. 2016 Jan 29. pii: CIRCULATIONAHA.115.016522.
    >> Share

  127. LAI YC, Tabima DM, Dube JJ, Hughan KS, et al
    SIRT3-AMPK Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF).
    Circulation. 2016 Jan 26. pii: CIRCULATIONAHA.115.018935.
    >> Share

  128. RIBEIRO AL, Duncan BB, Brant LC, Lotufo PA, et al
    Cardiovascular Health in Brazil: Trends and Perspectives.
    Circulation. 2016;133:422-33.
    >> Share

  129. ZHONG J, Cayir A, Trevisi L, Sanchez-Guerra M, et al
    Traffic-Related Air Pollution, Blood Pressure, and Adaptive Response of Mitochondrial Abundance.
    Circulation. 2016;133:378-87.
    >> Share

  130. BASU S, Yudkin JS, Sussman J, Millett C, et al
    Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target-Versus Risk-Based Blood Pressure Treatment.
    Circulation. 2016 Jan 13. pii: CIRCULATIONAHA.115.019985.
    >> Share

    December 2015
  131. DANIELS SR
    How to Define Hypertension in Children and Adolescents.
    Circulation. 2015 Dec 15. pii: CIRCULATIONAHA.115.020531.
    >> Share

  132. BLACK HR, Sica D, Ferdinand K, White WB, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Circulation. 2015;132:e298-302.
    >> Share

  133. WAXMAN AB, Farber HW
    Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
    Circulation. 2015;132:2152-61.
    >> Share

    November 2015
  134. ANDERSSON C, Vasan RS
    Lipophilic Statins and Aldosterone Secretion: A Bridge Too Far?
    Circulation. 2015;132:1783-5.
    >> Share

  135. GUAN J, Khambhati J, Jones LW, Morgans A, et al
    Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis.
    Circulation. 2015;132:e218-20.
    >> Share

  136. WATANABE Y, Miyata T, Tanemoto K
    Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity.
    Circulation. 2015;132:1701-9.
    >> Share

    October 2015
  137. KIM JB, Kim K, Lindsay ME, MacGillivray T, et al
    Risk of rupture or dissection in descending thoracic aortic aneurysm.
    Circulation. 2015;132:1620-9.
    >> Share

    September 2015
  138. ROTH GA, Nguyen G, Forouzanfar MH, Mokdad AH, et al
    Estimates of Global and Regional Premature Cardiovascular Mortality in 2025.
    Circulation. 2015;132:1270-82.
    >> Share

  139. CIRILLO PM, Cohn BA
    Pregnancy Complications and Cardiovascular Disease Death: Fifty-Year Follow-Up of the Child Health and Development Studies Pregnancy Cohort.
    Circulation. 2015 Sep 21. pii: CIRCULATIONAHA.113.003901.
    >> Share

  140. SHAH AM, Claggett B, Folsom AR, Lutsey PL, et al
    Ideal Cardiovascular Health During Adult Life and Cardiovascular Structure and Function Among the Elderly.
    Circulation. 2015 Sep 8. pii: CIRCULATIONAHA.115.017882.
    >> Share

  141. ASHRAFIAN H, Pal N, Sivaswamy N, Mahmod M, et al
    The Effect of Selective Heart Rate Slowing in Heart Failure with Preserved Ejection Fraction.
    Circulation. 2015 Sep 2. pii: CIRCULATIONAHA.115.017119.
    >> Share

    August 2015
  142. ABRAHAM TM, Pedley A, Massaro JM, Hoffman U, et al
    Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors.
    Circulation. 2015 Aug 20. pii: CIRCULATIONAHA.114.015000.
    >> Share

  143. GOLDSTEIN BI, Carnethon MR, Matthews KA, McIntyre RS, et al
    Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Aug 10. pii: CIR.0000000000000229.
    >> Share

  144. HAVRANEK EP, Mujahid MS, Barr DA, Blair IV, et al
    Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Aug 3. pii: CIR.0000000000000228.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016